Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Poor inhibitory control and stress as risk-factors for alcohol (mis)use during the COVID-19 pandemic in the UK: a national cross-sectional study across four generations

View ORCID ProfileJames M. Clay, View ORCID ProfileLorenzo D. Stafford, View ORCID ProfileMatthew O. Parker
doi: https://doi.org/10.1101/2020.09.24.20197293
James M. Clay
aDepartment of Psychology, King Henry Building, King Henry I Street, University of Portsmouth, PO1 2DY, UK
bBrain and Behaviour Laboratory, School of Pharmacy and Biomedical Sciences, University of Portsmouth, PO1 2DT, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James M. Clay
  • For correspondence: james.clay{at}port.ac.uk matthew.parker{at}port.ac.uk
Lorenzo D. Stafford
aDepartment of Psychology, King Henry Building, King Henry I Street, University of Portsmouth, PO1 2DY, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorenzo D. Stafford
Matthew O. Parker
bBrain and Behaviour Laboratory, School of Pharmacy and Biomedical Sciences, University of Portsmouth, PO1 2DT, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew O. Parker
  • For correspondence: james.clay{at}port.ac.uk matthew.parker{at}port.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Background The impact COVID-19 on the UK population’s alcohol intake is unknown. We assessed change in alcohol-use and hazardous drinking during the first lockdown, and tested the hypothesis that variation would be predicted by stress and inhibitory-control.

Methods We interrogated cross-sectional data from the first sweep of the COVID-19 longitudinal survey, comprising 4 national cohorts (13 453 respondents, 19-62 years). Respondents self-reported their alcohol use, stress, and inhibitory control. We regressed change in drinking and alcohol misuse on stress and inhibitory control, adjusting for covariates to account for demographics.

Findings 29·08% 30-year-olds increased alcohol use post-COVID-19. Stress was a major contributing factor to increased alcohol use in 30-year olds (adjusted OR 3·92, 95% CI 1·17 - 13·15), as was inhibitory control in 19-year-olds (adjusted OR 1·14, 95% CI 1·05 - 1·23), 30-year-olds (adjusted OR 1·18, 95% CI 1.05 - 1.33) and 50-year-olds (adjusted OR 1·06, 95% CI 1·01 - 1·12). We identified several interactions between stress and inhibitory control in all age groups, suggesting a complex age-specific relationship between the risk factors and alcohol use and misuse during the pandemic.

Interpretation In the UK, alcohol use increased in up to 30% of the population during COVID-19, resulting from a combination of factors including poor inhibitory control and stress. It is critical in future lockdowns that clinicians and public health officials are aware of the challenges faced by different age groups, and prioritise and personalise interventions and prevention measures appropriately.

Funding ESRC, Foundation for Liver Research.

Evidence before the study We searched PubMed, Web of Science, EBSCO Discovery, bioRxiv, medRxiv, and PsyArXiv for articles published between Jan 1, 2020 and Sep 1, 2020, with the following keywords: “covid-19”, “coronavirus”, and “alcohol”. We prioritised the selection of references based on relevance, importance, opportunity for further reading, and whether the work had been peer-reviewed. There have been several published articles that address the issue of alcohol use and misuse during COVID– 19, including a number of editorials and some limited empirical work. There were no nationally representative studies about alcohol use in the UK. In addition, all of the studies identified simply reported figures of those using alcohol during the pandemic, and to the best of our knowledge, none covered risk-factors for alcohol misuse.

Added value of this study Using data from the COVID-19 national longitudinal survey (first sweep), comprising data from 18 000 people across five national cohorts (aged 19-74), we tested the hypothesis that people who reported higher levels of stress, and who self-reported low impulse-control, would show higher rates of alcohol use/misuse during the pandemic lockdown. First, we show the proportion of adults across the UK that are drinking more during the pandemic, and how this differs by age and gender. Second, we show that while higher levels of stress were associated with higher levels of alcohol intake in some (e.g., 30-year-olds), we found that the relationship was complex and multifaceted. Stress-induced alcohol use and misuse was dependent on age and personality characteristics, with low impulse-control predictive of higher levels of alcohol consumption in 19-, 30- and 50-year-olds, and several stress x personality interactions.

Implications of all the available evidence Stress, as well as poor inhibitory control, were risk factors for the susceptibility to increased alcohol intake and hazardous drinking during the early stages of the COVID-19 pandemic and lockdown. The government, healthcare professionals, and the global media should consider the impact of change of lifestyle and stress that might impact on alcohol consumption among at-risk individuals during any future lockdowns. Similarly, additional support for those that may go on to develop an alcohol use disorder or relapse needs to be put in place.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JMC is funded by an ESRC Doctoral Training Partnership grant. MOP receives funding from the Foundation for Liver Research. The funders had no role in study design, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The UCL Centre for Longitudinal Studies, who administered the survey, played no role in the analysis of the data, preparation of the manuscript, or decision to submit the manuscript for publication. All authors had full access to all data in the study. All authors were responsible for the decision to submit for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data used in this work were from the UK Data Service. The registration for the access to the data from UK Data Service was done via University of Portsmouth. Access to the data was given by UK Data Service with the Project Number: 197137. As a secondary analysis was carried out, full ethical review was not required. Thus, the University of Portsmouth Ethics Screening Tool was used for assessment (reference number: ETHICS-10155).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in this study are available from the UK Data Service Website (https://ukdataservice.ac.uk/) under the "Safeguarded" data access policy. The primary dataset used is referenced under study number 8658. Ethnicity data associated with the MCS, Next Steps, BCS70, and NCDS cohorts are referenced under study numbers 6073, 5545, 5558, and 5565 respectively. All analysis code is available on the Open Science Framework website (https://osf.io/wf2rj/).

https://osf.io/wf2rj/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Poor inhibitory control and stress as risk-factors for alcohol (mis)use during the COVID-19 pandemic in the UK: a national cross-sectional study across four generations
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Poor inhibitory control and stress as risk-factors for alcohol (mis)use during the COVID-19 pandemic in the UK: a national cross-sectional study across four generations
James M. Clay, Lorenzo D. Stafford, Matthew O. Parker
medRxiv 2020.09.24.20197293; doi: https://doi.org/10.1101/2020.09.24.20197293
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Poor inhibitory control and stress as risk-factors for alcohol (mis)use during the COVID-19 pandemic in the UK: a national cross-sectional study across four generations
James M. Clay, Lorenzo D. Stafford, Matthew O. Parker
medRxiv 2020.09.24.20197293; doi: https://doi.org/10.1101/2020.09.24.20197293

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1163)
  • Epidemiology (13336)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5127)
  • Geriatric Medicine (479)
  • Health Economics (780)
  • Health Informatics (3250)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4898)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1700)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (493)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)